Department of Internal Medicine, Hallym University Sacred Heart Hospital, University of Hallym College of Medicine, 22 Gwanpyeong-ro 170-gil, Dongan-gu, Anyang, 14068, Republic of Korea.
Department of Internal Medicine, Kirk Kerkorian School of Medicine, University of Nevada Las Vegas, Las Vegas, NV, USA.
BMC Gastroenterol. 2022 Dec 21;22(1):532. doi: 10.1186/s12876-022-02627-w.
Appendiceal orifice inflammation (AOI) or peri-appendiceal red patch is a skip lesion with segments of continuous colitis from the rectum. Frequently observed in ulcerative colitis (UC) patients, this lesion might be associated with proximal extension in some studies. However, the clinical significance of this lesion and long-term outcomes including therapy remain unclear. Thus, the aim of this study was to evaluate the clinical implication of AOI during long-term periods in patients with UC.
We retrospectively reviewed 376 patients with UC who performed complete colonoscopic examinations between April 2000 and December 2020. We compared clinical characteristics and outcomes of patients manifesting AOI with those who did not show AOI during a mean follow-up period of 66.1 months. Long-term outcomes included maximal extent of colitis, proximal extension, therapeutic medical histories, UC-related hospitalization, and relapse.
Ninety-eight (26.1%) patients showed AOI without evidence of inflammation in the right colon. Mild disease activity at the diagnosis of UC was more included in patients with AOI than in those without AOI. Other baseline characteristics including disease extent, smoking history, external intestinal manifestation, and terminal ileal ulceration were not significantly different between the two groups. During follow-up periods, patients with and without AOI showed no significant difference in proximal extension, Mayo endoscopic score at the last endoscopic examination, UC-related hospitalization, or relapse. Of medication history, patients with AOI were less included in the group treated with high-dose aminosalicylates than those without AOI. However, therapeutic histories of steroids, immunosuppressive agents, and biologics were not significantly different. Of 62 patients with AOI who underwent follow-up colonoscopy, 36 (58.1%) showed resolution of AOI. Clinical outcomes of the resolution group were not different than those of the non-resolution group. Biopsy results of 77 patients with AOI showed chronic active or erosive colitis.
Long-term outcomes of UC patients with AOI were not different from those without AOI. Outcomes of resolution and non-resolution groups of AOI patients were not different either. Thus, AOI might have no prognostic implication in distal UC patients.
阑尾口炎(AOI)或阑尾周围红斑是一种跳跃性病变,表现为从直肠开始的连续结肠炎节段。在溃疡性结肠炎(UC)患者中经常观察到这种病变,在一些研究中,这种病变可能与近端扩展有关。然而,这种病变的临床意义以及包括治疗在内的长期结果尚不清楚。因此,本研究旨在评估 UC 患者在长期随访中 AOI 的临床意义。
我们回顾性分析了 2000 年 4 月至 2020 年 12 月期间接受全结肠镜检查的 376 例 UC 患者。我们比较了在平均 66.1 个月的随访期间表现出 AOI 与未出现 AOI 的患者的临床特征和结局。长期结局包括结肠炎的最大程度、近端扩展、治疗史、与 UC 相关的住院治疗和复发。
98 例(26.1%)患者表现出 AOI,但右半结肠无炎症证据。与无 AOI 的患者相比,有 AOI 的患者在 UC 诊断时的疾病活动度较轻。其他基线特征,包括疾病程度、吸烟史、肠外表现和末端回肠溃疡,在两组之间无显著差异。在随访期间,有和无 AOI 的患者在近端扩展、最后一次内镜检查的 Mayo 内镜评分、与 UC 相关的住院治疗或复发方面无显著差异。在药物治疗史方面,有 AOI 的患者接受高剂量氨基水杨酸盐治疗的比例低于无 AOI 的患者。然而,皮质类固醇、免疫抑制剂和生物制剂的治疗史无显著差异。在 62 例接受随访结肠镜检查的 AOI 患者中,36 例(58.1%)AOI 缓解。缓解组的临床结局与非缓解组无差异。77 例 AOI 患者的活检结果显示为慢性活动性或糜烂性结肠炎。
UC 患者有和无 AOI 的长期结局无差异。AOI 缓解和未缓解患者的结局也无差异。因此,在远端 UC 患者中,AOI 可能没有预后意义。